Where genes meet environment-integrating the role of gut luminal contents, immunity and pancreas in type 1 diabetes.
The rise in new cases of type 1 diabetes (T1D) in genetically susceptible individuals over the past half century has been attributed to numerous environmental "triggers" or promoters such as enteroviruses, diet, and most recently, gut bacteria. No single cause has been identified in humans, likely because there are several pathways by which one can develop T1D. There is renewed attention to the role of the gut and its immune system in T1D pathogenesis based largely on recent animal studies demonstrating that altering the gut microbiota affects diabetes incidence. Although T1D patients display dysbiosis in the gut microbiome, it is unclear whether this is cause or effect. The heart of this question involves several moving parts including numerous risk genes, diet, viruses, gut microbiota, timing, and loss of immune tolerance to β-cells. Most clinical trials have addressed only one aspect of this puzzle using some form of immune suppression, without much success. The key location where our genes meet and deal with the environment is the gastrointestinal tract. The influence of all of its major contents, including microbes, diet, and immune system, must be understood as part of the integrative biology of T1D before we can develop durable means of preventing, treating, or curing this disease. In the present review, we expand our previous gut-centric model based on recent developments in the field.
Chronic Disease Program, The Ottawa Hospital Research Institute, Ottawa, Canada; Department of Medicine, University of Ottawa, Ottawa, Canada; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada. Electronic address: fscott@ohri.ca.
Fraser W
FW
Scott
Chronic Disease Program, The Ottawa Hospital Research Institute, Ottawa, Canada.
Lynley D
LD
Pound
Chronic Disease Program, The Ottawa Hospital Research Institute, Ottawa, Canada.
Christopher
C
Patrick
Chronic Disease Program, The Ottawa Hospital Research Institute, Ottawa, Canada; Department of Medicine, University of Ottawa, Ottawa, Canada.
Chandra E
CE
Eberhard
Chronic Disease Program, The Ottawa Hospital Research Institute, Ottawa, Canada.
Jennifer A
JA
Crookshank
D000818:Animals; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism* / Q000473:pathology*; D041981:Gastrointestinal Tract / Q000378:metabolism*; D059647:Gene-Environment Interaction; D006801:Humans; D007109:Immunity / Q000235:genetics*; D008954:Models, Biological; D010179:Pancreas / Q000378:metabolism* / Q000473:pathology*